COMMUNIQUÉS West-GlobeNewswire

Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update

09/08/2018 - 22:05

MENLO PARK, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]

Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals

09/08/2018 - 22:05

Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019 Lead IND program for Alpha-1-antitrypsin deficiency (“A1AT”) expected to commence IND-enabling studies in second half of [...]

Resonant Inc. Reports Second Quarter 2018 Financial Resultsand Provides Business Update and Financial Outlook

09/08/2018 - 22:05

- Secured two new customer engagements - - Increased number of devices under contract to more than 60 - - Grew number of devices under qualification to 14 - GOLETA, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Resonant Inc [...]

Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights

09/08/2018 - 22:05

Gimoti ™ NDA submitted to FDA on June 1 st ; awaiting 74-Day FDA filing communication letter Gender-specific patents granted for Gimoti in the European Union and Mexico SOLANA BEACH, Calif., Aug. 09, 2018 (GLOBE [...]

KemPharm, Inc. Reports Second Quarter 2018 Results

09/08/2018 - 22:05

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development Highlights: Announced top line results from KP415.E01 efficacy and safety trial in children with ADHD [...]

Apricus Biosciences Provides Corporate Update and Second Quarter 2018 Financial Results

09/08/2018 - 22:05

Company Enters Into Merger Agreement with Seelos Therapeutics, Inc. Apricus Shareholders Expected to Own ~14% of Combined Company Based on Estimated $90 Million Valuation at Closing Merger Expected to Close in Fourth [...]

Fortress Biotech Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

09/08/2018 - 22:05

NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections

09/08/2018 - 22:05

First of three planned Phase 3 pivotal trials now underway for Iterum’s oral antibiotic Oral sulopenem, if approved, could be the first antibiotic for uncomplicated urinary tract infections in over 20 years Top-line [...]

Caladrius Biosciences Reports 2018 Second Quarter and First Six Months Financial Results

09/08/2018 - 22:05

Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a development-stage [...]

Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 22:02

Company reports 80% growth in total quarterly revenue year-over-year Multiple clinical and regulatory milestones achieved for Viveve ® System ENGLEWOOD, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Viveve Medical Inc. ( [...]

TearLab Corporation Reports Second Quarter and First Half 2018 Financial Results

09/08/2018 - 22:01

SAN DIEGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter ended June 30, 2018. All dollar [...]

Opiant Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 22:01

SANTA MONICA, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]

CymaBay Reports Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 22:01

Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY) a clinical-stage biopharmaceutical company focused on developing therapies for [...]

Ovid Therapeutics Reports Second Quarter 2018 Financial Results and Highlights Recent Clinical Progress

09/08/2018 - 22:01

-- OV101 in Angelman syndrome: plan to initiate an open-label extension study (ELARA) in the fourth quarter of 2018 and discuss with regulatory authorities next steps for a registrational pathway based on positive Phase [...]

Corium Reports Third Quarter Fiscal 2018 Financial Results and Corporate Highlights

09/08/2018 - 22:01

MENLO PARK, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Cytori Reports Publication of Interim Pilot Data for Cell Therapy in Vocal Fold Scarring

09/08/2018 - 15:25

SAN DIEGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced publication in the peer-reviewed journal, Stem Cell Research and Therapy, of “Autologous adipose-derived stromal vascular [...]

RedHill Biopharma Announces Pricing of $25 Million Underwritten Offering

09/08/2018 - 15:09

TEL-AVIV, Israel and RALEIGH, N.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Vaccinex Announces Pricing of Initial Public Offering

09/08/2018 - 15:08

ROCHESTER, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Vaccinex), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]

Healthwise Announces Jay Reynolds as Chief Technology Officer

09/08/2018 - 15:07

BOISE, Idaho, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology and services, announced that Jay Reynolds has assumed the position of Chief Technology Officer (CTO). [...]